Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Immupharma (IMM) Share Price

Price 2.44p on 15-04-2025 at 05:00:04
Change 0.00p 0%
Buy 0.00p
Sell 0.00p
Buy / Sell IMM Shares
Last Trade: Sell 34,549.00 at 2.3028p
Day's Volume: 0
Last Close: 2.44p
Open: 0.00p
ISIN: GB0033711010
Day's Range 0.00p - 0.00p
52wk Range: 0.85p - 7.26p
Market Capitalisation: £10m
VWAP: 0.00p
Shares in Issue: 416m

Immupharma (IMM) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 34,549 2.3028p Ordinary
14:53:35 - 14-Apr-25
Sell* 5,000 2.3062p Ordinary
14:24:39 - 14-Apr-25
Buy* 37,476 2.495p Ordinary
14:21:32 - 14-Apr-25
Buy* 86 2.58p SI Trade
14:16:46 - 14-Apr-25
Sell* 75,000 2.40p Automatic Execution
14:16:46 - 14-Apr-25
Sell* 54,184 2.4042p Ordinary
14:14:30 - 14-Apr-25
Buy* 197 2.526p Ordinary
14:01:23 - 14-Apr-25
Sell* 4,326 2.404p Ordinary
13:51:25 - 14-Apr-25
Sell* 53,000 2.45p Ordinary
13:25:13 - 14-Apr-25
Sell* 10,000 2.40p Ordinary
13:07:16 - 14-Apr-25
See more Immupharma trades

Immupharma (IMM) Share Price History

Time period:
to
Date Open High Low Close Volume
14th Apr 2025 (Mon) 2.40 2.40 2.40 2.44 692,292
11th Apr 2025 (Fri) 2.50 2.58 2.40 2.57 778,493
10th Apr 2025 (Thu) 2.45 2.78 2.32 2.56 504,310
9th Apr 2025 (Wed) 2.14 2.35 2.14 2.15 1,073,208
8th Apr 2025 (Tue) 2.55 2.55 2.30 2.50 1,143,919
7th Apr 2025 (Mon) 2.40 2.61 2.26 2.61 4,087,716
4th Apr 2025 (Fri) 2.50 3.00 2.40 2.375 4,728,328
3rd Apr 2025 (Thu) 2.50 2.95 2.50 2.65 4,608,745
2nd Apr 2025 (Wed) 2.80 2.80 2.56 2.665 7,287,920
1st Apr 2025 (Tue) 2.90 2.90 2.90 2.90 3,443,092
31st Mar 2025 (Mon) 3.04 3.04 3.04 3.05 3,483,043
28th Mar 2025 (Fri) 3.00 3.00 3.00 2.94 1,975,056
27th Mar 2025 (Thu) 3.20 3.20 2.80 3.055 6,150,808
26th Mar 2025 (Wed) 3.30 3.30 3.19 3.19 3,770,714
25th Mar 2025 (Tue) 3.27 3.27 3.27 3.30 2,176,640
24th Mar 2025 (Mon) 3.34 3.44 3.34 3.44 1,438,176
21st Mar 2025 (Fri) 3.40 3.57 3.38 3.50 3,064,636
20th Mar 2025 (Thu) 3.33 3.33 3.11 3.34 1,349,081
19th Mar 2025 (Wed) 3.40 3.40 3.11 3.40 1,671,350
18th Mar 2025 (Tue) 3.48 3.53 3.35 3.40 1,161,888
17th Mar 2025 (Mon) 3.32 3.90 3.32 3.56 6,061,828
See more Immupharma price history

Immupharma (IMM) Share News

ImmuPharma celebrates "significant milestone" for P140 platform

13th Mar 2025 16:27

(Alliance News) - ImmuPharma PLC on Thursday announced "new discoveries" regarding the mechanism of action of its P140 autoimmune technology platform. Read More

AIM WINNERS & LOSERS: Hornby plots AIM exit; Ethernity deal progresses

13th Mar 2025 11:07

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

IN BRIEF: ImmuPharma notes share price surge after novel findings

28th Jan 2025 14:28

ImmuPharma PLC - London-based specialist drug discovery and development company - Notes recent movements in its share price, as it has more than multiplied nearly five times higher in the last month to 6.03p per share, from 1.21p. The stock surged 94% higher in a single day in early January, to 2.33p, after ImmuPharma reported breakthrough findings in its preclinical research programme focused on P140 and the pathogenesis of autoimmune diseases. Read More

IN BRIEF: ImmuPharma shares climb on breakthrough autoimmune findings

9th Jan 2025 11:21

ImmuPharma PLC - London-based specialist drug discovery and development company - Says its preclinical research program focused on P140 and the pathogenesis of autoimmune diseases has yielded data that provides novel insights into autoimmune mechanisms. P140, the firms lead programme, is a unique non-immunosuppressive peptide for the treatment of systemic lupus erythematosus and chronic idiopathic demyelinating polyneuropathy. Adds that the findings, which were discovered by its R&D subsidiary ImmuPharma Biotech, pave the way for better diagnostics, identifying patients most likely to respond to P140 therapy and improved patient monitoring. Says the research marks a "significant step towards personalised medicine in SLE and other autoimmune diseases." Details of the data findings are not being released at this time since they form part of the ongoing expansion of the firms intellectual property portfolio. Read More

AIM WINNERS & LOSERS: ImmuPharma jumps; Impax Asset hit by outflows

9th Jan 2025 09:53

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday. Read More

See more Immupharma news
FTSE 100 Latest
Value8,134.34
Change0.00

Login to your account

Forgot Password?

Not Registered